Aligos Therapeutics, Inc. (ALGS) Operating income 2019–2025
Aligos Therapeutics, Inc. (ALGS) annual operating income history from SEC filings — each fiscal year as reported.
-$88.0MFY2025 · since FY2019: -$54.0M → -$88.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$88.0M | +1.3% |
| FY2024 | -$89.2M | -1.2% |
| FY2023 | -$88.1M | +9.7% |
| FY2022 | -$97.6M | +24.0% |
| FY2021 | -$128.3M | -31.2% |
| FY2020 | -$97.8M | -81.0% |
| FY2019 | -$54.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice